Drugs@FDA document
CLOZAPINE Letter · ANDA 075417 SUPPL-21
Drugs@FDA document · MYLAN · Apr 28, 2010
Key facts
| Drug name | CLOZAPINE |
|---|---|
| Document type | Letter |
| Application | ANDA075417 |
| Submission | SUPPL-21 |
| Company | MYLAN |
| Document date | Apr 28, 2010 |
| FDA document | accessdata.fda.gov |
At a glance
- Efficacy-New Dosing Regimen Document categories
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: